Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,900 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 December 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 4MB, 245 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website

 

 

Export 16 results:
Author Title Type [ Year(Asc)]
Filters: Author is Douros, A.  [Clear All Filters]
2021
A. Douros, Santella, C., Dell'Aniello, S., Azoulay, L., Renoux, C., Suissa, S., and Brassard, P., Infectious Disease Burden and the Risk of Alzheimer's Disease: A Population-Based Study, J Alzheimers Dis, 2021.
K. Suissa, Schneeweiss, S., Douros, A., Filion, K. B., Yin, H., Patorno, E., and Azoulay, L., The modifying effects of adiposity on the cardiovascular safety of sulphonylureas, Diabetes Obes Metab, 2021.
T. Jiao, Platt, R. W., Douros, A., and Filion, K. B., Prescription Patterns for the Use of Antihypertensive Drugs for Primary Prevention among Patients with Hypertension in the United Kingdom, Am J Hypertens, 2021.
A. Douros, Cui, Y., Platt, R. W., Filion, K. B., Sebastiani, G., and Renoux, C., Utilization and long-term persistence of direct oral anticoagulants among patients with non-valvular atrial fibrillation and liver disease, Br J Clin Pharmacol, 2021.
L. M. Lix, Sobhan, S., St-Jean, A., Daigle, J. M., Fisher, A., Yu, O. H. Y., Dell'Aniello, S., Hu, N., Bugden, S. C., Shah, B. R., Ronksley, P. E., Alessi-Severini, S., Douros, A., Ernst, P., and Filion, K. B., Validity of an algorithm to identify cardiovascular deaths from administrative health records: a multi-database population-based cohort study, BMC Health Serv Res, vol. 21, p. 758, 2021.
2018
D. Abrahami, Douros, A., Yin, H., Yu, O. H. Y., Renoux, C., Bitton, A., and Azoulay, L., Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study, Bmj, vol. 360, p. k872, 2018.
A. Douros, Filion, K. B., Yin, H., Yu, O. H., Etminan, M., Udell, J. A., and Azoulay, L., Glucagon-Like Peptide 1 Receptor Agonists and the Risk of Incident Diabetic Retinopathy, Diabetes Care, vol. 41, pp. 2330-2338, 2018.
D. Abrahami, Douros, A., Yin, H., Yu, O. H., Faillie, J. L., Montastruc, F., Platt, R. W., Bouganim, N., and Azoulay, L., Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study, Bmj, vol. 363, p. k4880, 2018.
A. Douros, Dell'Aniello, S., Yu, O. H. Y., Filion, K. B., Azoulay, L., and Suissa, S., Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study, Bmj, vol. 362, p. k2693, 2018.
A. Douros, Abrahami, D., Yin, H., Yu, O. H. Y., Renoux, C., Hudson, M., and Azoulay, L., Use of Dipeptidyl Peptidase-4 Inhibitors and New-onset Rheumatoid Arthritis in Patients with Type 2 Diabetes, Epidemiology, vol. 29, pp. 904-912, 2018.
[Page last reviewed 6 December 2021]